Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Non-Current Assets (2023 - 2026)

Beta Bionics' Non-Current Assets history spans 4 years, with the latest figure at $56.4 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 25.86% to $56.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $221.2 million, a N/A change, with the full-year FY2025 number at $60.8 million, up 263.82% from a year prior.
  • Non-Current Assets hit $56.4 million in Q1 2026 for Beta Bionics, down from $60.8 million in the prior quarter.
  • Over the last five years, Non-Current Assets for BBNX hit a ceiling of $76.1 million in Q1 2025 and a floor of $6.4 million in Q4 2023.
  • Historically, Non-Current Assets has averaged $45.8 million across 4 years, with a median of $56.4 million in 2026.
  • Biggest five-year swings in Non-Current Assets: soared 263.82% in 2025 and later decreased 25.86% in 2026.
  • Tracing BBNX's Non-Current Assets over 4 years: stood at $6.4 million in 2023, then surged by 160.51% to $16.7 million in 2024, then soared by 263.82% to $60.8 million in 2025, then dropped by 7.24% to $56.4 million in 2026.
  • Business Quant data shows Non-Current Assets for BBNX at $56.4 million in Q1 2026, $60.8 million in Q4 2025, and $60.0 million in Q3 2025.